Octimibate, a potent non‐prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor
Janet E. Merritt(New Frontier), T J Rink(New Frontier), John MacDermot(London Postgraduate Medical and Dental Education), Ursula Kozlowski(New Frontier), Albert Jaxa‐Chamiec(New Frontier), Eamonn Kelly(University of Bristol), Kitty Moores(GlaxoSmithKline (United Kingdom)), Trevor J. Hallam(New Frontier), Deirdre M. B. Hickey(New Frontier), David G. Cooper(New Frontier), Mary Keen(National Institute for Medical Research), Kenneth Murray(New Frontier), Alberto J. Kaumann(New Frontier), James A. Lynham(New Frontier), Anthony Brown(New Frontier), Isobel Boyfield(New Frontier)
Cited by 45
Related Papers
The Concise Guide to PHARMACOLOGY 2015/16: G protein‐coupled receptors
|British Journal of Pharmacology|2015|849
THE CONCISE GUIDE TO PHARMACOLOGY 2019/20: G protein‐coupled receptors
|British Journal of Pharmacology|2019|712
The Concise Guide to PHARMACOLOGY 2015/16: Enzymes
|British Journal of Pharmacology|2015|603
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: Enzymes
|British Journal of Pharmacology|2017|597
THE CONCISE GUIDE TO PHARMACOLOGY 2017/18: G protein‐coupled receptors
|British Journal of Pharmacology|2017|589